Advertisement
Advertisement

AXSM

AXSM logo

Axsome Therapeutics, Inc

205.40
USD
Sponsored
-2.37
-1.14%
Aug 24, 15:59 UTC -4
Closed
exchange

After-Market

205.50

+0.10
+0.05%

Axsome Therapeutics, Inc Profile

About

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS), disorders for which there are limited treatment options available.

Info & Links

CEO

Herriot Tabuteau

Headquarters

One World Trade Center,22nd Floor
NEW YORK, NY 10007, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://www.axsome.com/

Auditor

Deloitte & Touche LLP

Share holders

5

Employees

925

Axsome Therapeutics, Inc Statistics

Valuation Measures

Market Capitalization2

10.76B

Enterprise Value

10.64B

Enterprise Value/EBITDA(ttm)

-60.64

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

14.01

Price to Book(mrq)

128.35

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

93.21%

Operating Margin(ttm)

-25.64%

Profit Margin(ttm)

-24.86%

Return on Equity(ttm)

-265.55%

Return on Invested Capital(ttm)

-98.28%

Return on Assets(ttm)

-28.10%

Income Statement

Revenue(ttm)

776.57M

Revenue Per Share(ttm)

14.83

Gross Profit(ttm)

724.04M

EBITDA(ttm)3

-175.49M

Net Income Available to Common(ttm)

-191.64M

Diluted EPS(ttm)

-3.75

Share Statistics

Beta (5Y Monthly)

0.65

52-Week Change

73.32%

S&P 500 52-Week Change

18.66%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

52.38M

Dividend Yield

0.00%

Float4

41.59M

% Held by Insiders

20.60%

% Held by Institutions

81.49%

Balance Sheet

Total Cash(mrq)

319.85M

Total Cash Per Share(mrq)

6.11

Total Debt(mrq)

196.99M

Total Debt/Equity(mrq)

236.47%

Current Ratio(mrq)

1.43%

Quick Ratio(mrq)

1.34%

Book Value Per Share(mrq)

1.59

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.04

Free Cash Flow(ytd)

-54.22M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement